These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12376059)

  • 21. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
    Speert DP; Henry D; Vandamme P; Corey M; Mahenthiralingam E
    Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taxonomy and pathogenesis of the Burkholderia cepacia complex.
    Mahenthiralingam E; Vandamme P
    Chron Respir Dis; 2005; 2(4):209-17. PubMed ID: 16541604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.
    Kazachkov M; Lager J; LiPuma J; Barker PM
    Pediatr Pulmonol; 2001 Oct; 32(4):338-40. PubMed ID: 11568995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors.
    Ganesh PS; Vishnupriya S; Vadivelu J; Mariappan V; Vellasamy KM; Shankar EM
    Microbiol Immunol; 2020 Feb; 64(2):87-98. PubMed ID: 31769530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burkholderia cepacia complex infection in patients with cystic fibrosis.
    Mahenthiralingam E; Baldwin A; Vandamme P
    J Med Microbiol; 2002 Jul; 51(7):533-538. PubMed ID: 12132768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?
    LiPuma JJ
    Transpl Infect Dis; 2001 Sep; 3(3):149-60. PubMed ID: 11493397
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Narayanaswamy VP; Duncan AP; LiPuma JJ; Wiesmann WP; Baker SM; Townsend SM
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910901
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
    Henry DA; Campbell ME; LiPuma JJ; Speert DP
    J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burkholderia cepacia infections in cystic fibrosis.
    Burns JL; Saiman L
    Pediatr Infect Dis J; 1999 Feb; 18(2):155-6. PubMed ID: 10048690
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.
    Messiaen AS; Nelis H; Coenye T
    J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
    Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR
    J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia.
    Ledson MJ; Gallagher MJ; Robinson M; Cowperthwaite C; Williets T; Hart CA; Walshaw MJ
    J Aerosol Med; 2002; 15(1):51-7. PubMed ID: 12006145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients.
    Millar-Jones L; Ryley HC; Paull A; Goodchild MC
    Respir Med; 1998 Feb; 92(2):178-83. PubMed ID: 9616509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
    Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS
    J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Burkholderia cepacia: a new pathogen causing nosocomial infections].
    Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E
    Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.
    Vandamme P; Henry D; Coenye T; Nzula S; Vancanneyt M; LiPuma JJ; Speert DP; Govan JR; Mahenthiralingam E
    FEMS Immunol Med Microbiol; 2002 Jun; 33(2):143-9. PubMed ID: 12052570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis.
    De Soyza A; McDowell A; Archer L; Dark JH; Elborn SJ; Mahenthiralingam E; Gould K; Corris PA
    Lancet; 2001 Nov; 358(9295):1780-1. PubMed ID: 11734238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of Burkholderia cepacia in the hospital environment.
    Moore JE; McIlhatton B; Buchanan J; Gilpin D; Shaw A; Hall V; Murphy PG; Elborn JS
    Ir J Med Sci; 2002; 171(3):131-3. PubMed ID: 15736349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the Burkholderia cepacia complex.
    Lipuma JJ
    Curr Opin Pulm Med; 2005 Nov; 11(6):528-33. PubMed ID: 16217180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.
    Vermis K; Vandekerckhove C; Nelis HJ; Vandamme PA
    FEMS Microbiol Lett; 2002 Aug; 214(1):1-5. PubMed ID: 12204364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.